Objective: Pre-clinical studies and clinical trials for the application of nano vesicles of epidermal growth factor (EGF) by topical route to patients who present ulcers due to chronic venous insufficiency of long evolution to facilitate the epithelization and the closing of the ulcer.
Innovation: Development of an innovative vehicle carrying the active ingredient
Expected result: Progress in the clinical phase of development of the molecule to have a prototype to test.